Literature DB >> 26136854

Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.

Augustine Lau1, Steve Malangone2, Myke Green2, Ambuga Badari3, Kathryn Clarke2, Emad Elquza4.   

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.

Entities:  

Keywords:  bevacizumab; capecitabine; epithelioid; hemangioendothelioma; heptatic; metastatic

Year:  2015        PMID： 26136854      PMCID： PMC4480525          DOI： 10.1177/1758834015582206

Source DB:  PubMed          Journal:  Ther Adv Med Oncol        ISSN： 1758-8340            Impact factor:   8.168


  45 in total

1.  Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab.

Authors:  Young Hak Kim; Michiaki Mishima; Aya Miyagawa-Hayashino
Journal:  J Thorac Oncol       Date:  2010-07       Impact factor: 15.609

2.  Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.

Authors:  Jan Pintoffl; Ines Meisinger; Frank Mayer; Marius Horger; Claus von Weyhern; Lothar Kanz; Joerg Thomas Hartmann
Journal:  Anticancer Drugs       Date:  2009-01       Impact factor: 2.248

3.  Pulmonary epithelioid haemangioendothelioma and bevacizumab.

Authors:  Laure Belmont; Leila Zemoura; Louis Jean Couderc
Journal:  J Thorac Oncol       Date:  2008-05       Impact factor: 15.609

Review 4.  Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy.

Authors:  Arianeb Mehrabi; Arash Kashfi; Hamidreza Fonouni; Peter Schemmer; Bruno M Schmied; Peter Hallscheidt; Peter Schirmacher; Jurgen Weitz; Helmut Friess; Markus W Buchler; Jan Schmidt
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

5.  Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases.

Authors:  H R Makhlouf; K G Ishak; Z D Goodman
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

6.  Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up.

Authors:  Felipe Salech; Sebastián Valderrama; Bruno Nervi; Juan Carlos Rodriguez; Danny Oksenberg; Alvaro Koch; Gladys Smok; Ignacio Duarte; Rosa María Pérez-Ayuso; Nicolás Jarufe; Jorge Martínez; Alejandro Soza; Marco Arrese; Arnoldo Riquelme
Journal:  Ann Hepatol       Date:  2011 Jan-Mar       Impact factor: 2.400

Review 7.  Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor.

Authors:  J M Läuffer; A Zimmermann; L Krähenbühl; J Triller; H U Baer
Journal:  Cancer       Date:  1996-12-01       Impact factor: 6.860

Review 8.  Primary pleural epithelioid haemangioendothelioma with metastases to the skin. A case report and literature review.

Authors:  M Al-Shraim; B Mahboub; P C Neligan; D Chamberlain; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

9.  Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease.

Authors:  Ashley Sumrall; Ruth Fredericks; Anne Berthold; Grace Shumaker
Journal:  J Neurooncol       Date:  2009-11-07       Impact factor: 4.130

10.  Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases.

Authors:  Jon Cardinal; Michael E de Vera; James W Marsh; Jennifer L Steel; David A Geller; Paulo Fontes; Michael Nalesnik; T Clark Gamblin
Journal:  Arch Surg       Date:  2009-11
View more
  8 in total

1.  Hepatic Epithelioid Hemangioendothelioma - a Rare Tumor and Diagnostic Dilemma.

Authors:  Vladislav Treska; Ondrej Daum; Martin Svajdler; Vaclav Liska; Jiri Ferda; Jan Baxa
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

2.  Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.

Authors:  Wei-Fang Mo; Yu-Ling Tong
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 3.  Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.

Authors:  Ari Rosenberg; Mark Agulnik
Journal:  Curr Treat Options Oncol       Date:  2018-03-15

4.  Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?

Authors:  Ilias Kounis; Maïté Lewin; Astrid Laurent-Bellue; Edoardo Poli; Audrey Coilly; Jean-Charles Duclos-Vallée; Catherine Guettier; René Adam; Jan Lerut; Didier Samuel; Olivier Rosmorduc
Journal:  Ther Adv Med Oncol       Date:  2022-03-23       Impact factor: 8.168

5.  Suprasellar epithelioid hemangioendothelioma: Case report and review of the literature.

Authors:  James Barger; Omar Tanweer; Benjamin Liechty; Matija Snuderl; Jafar J Jafar
Journal:  Surg Neurol Int       Date:  2016-09-01

Review 6.  Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.

Authors:  John M Lamar; Vijeyaluxmy Motilal Nehru; Guy Weinberg
Journal:  Cancers (Basel)       Date:  2018-07-10       Impact factor: 6.639

Review 7.  Hepatic Hemangioendothelioma: An update.

Authors:  Mayur Virarkar; Mohammed Saleh; Radwan Diab; Melissa Taggart; Peeyush Bhargava; Priya Bhosale
Journal:  World J Gastrointest Oncol       Date:  2020-03-15

Review 8.  Laparoscopic resection of hepatic epithelioid hemangioendothelioma: report of eleven rare cases and literature review.

Authors:  Jianjun Xu; Shaobo Hu; Suzhen Li; Weimin Wang; Xing Zhou; Yuzhe Wu; Zhe Su; Xiang Cheng; Yang Gao; Qichang Zheng
Journal:  World J Surg Oncol       Date:  2020-10-29       Impact factor: 2.754
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.